Glioblastoma multiforme epidemiology and demographics

Glioblastoma multiforme Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glioblastoma multiforme from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Glioblastoma multiforme epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Glioblastoma multiforme epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Glioblastoma multiforme epidemiology and demographics
CDC on Glioblastoma multiforme epidemiology and demographics
Glioblastoma multiforme epidemiology and demographics in the news
Blogs on Glioblastoma multiforme epidemiology and demographics
Directions to Hospitals Treating Glioblastoma multiforme
Risk calculators and risk factors for Glioblastoma multiforme epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

• Glioblastoma multiforme accounts for for 52% of all primary brain tumor cases and 20% of all intracranial tumors.
• Despite being the most prevalent form of primary brain tumor, GBMs occur in only 2-3 cases per 100,000 people in Europe and North America.

References

Template:WikiDoc Sources